References
- Huzly, D., T. Schenk, W. Jilg, and D. Neumann-Haefelin (2008) Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen. J. Clin. Microbiol. 46: 1298-1306. https://doi.org/10.1128/JCM.02430-07
- Haas, J. and G. Hotz (1980) Rapid detection of HBsAg and anti-HBs by enzyme-immunoassay. J. Virol. Methods 2: 63-69. https://doi.org/10.1016/0166-0934(80)90040-3
- Kruining, J., P. G. Mulder, and R. A. Heijtink (1988) Immune response to HBsAg differently interpreted by RIA and EIA. J. Virol. Methods 22: 89-98. https://doi.org/10.1016/0166-0934(88)90091-2
- Ostrow, D. H., B. Edwards, D. Kimes, J. Macioszek, H. Irace, L. Nelson, K. Bartko, J. Neva, C. Krenc, and L. Mimms (1991) Quantitation of hepatitis B surface antibody by an automated microparticle enzyme immunoassay. J. Virol. Methods. 32: 265-276. https://doi.org/10.1016/0166-0934(91)90057-7
- Racela, L. S., G. E. Tegtmeier, G. R. Hodges, and J. S. Reed (1986) Comparison of two testing methods to determine hepatitis B surface antibody response to hepatitis B vaccine among healthcare workers. Am. J. Clin. Pathol. 86: 527-529. https://doi.org/10.1093/ajcp/86.4.527
- EP (2007) Monograph Human Hepatitis B Immunoglobulin. pp. 2068-2069 European Pharmacopoeia 6.0. European Directorate for the Quality of Medicines (EDQM) Council of Europe, Strasbourg, France.
- FDA (2000) Analytical Procedures and Methods Validation. FDA Guidance for Industry, White Oak, Maryland, USA.
- KFDA (2005) Monograph Human Hepatitis B Immunoglobulin. pp. 589-591. Biologics Test and Specification. Korea Food and Drug Administration, Seoul, Korea.
- EP (2007) Statistical analysis of results of biological assays and tests. pp. 571-600. European Pharmacopoeia 6.0, European Directorate for the Quality of Medicines (EDQM) Council of Europe, Strasbourg, France.